⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2024Open Access

Supplemental Figure 6 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis

Esteban J. Rozen William Tyler Frantz Kim Wigglesworth Theadora Vessella H. Susan Zhou Jason M. Shohet

View Full Paper

Ask AI

Bookmark

Share

Abstract

Overexpression of DDR2 in 293 T cells renders these cells less sensitive to Sitravatinib inhibition of DDR2 signaling.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rozen et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e0b6db643587574b58 https://doi.org/10.1158/1535-7163.26424076.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Figure 6 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis2024
2Supplemental Figure 8 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis2024
3Supplemental Figure 8 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis2024
4Supplemental Figure 3 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis2024
5Supplemental Figure 3 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis2024

Supplemental Figure 2 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis2024
Supplemental Figure 2 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis2024
Supplemental Figure 1 from Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis2024